Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Exp Biol Med (Maywood). 2004 Sep;229(8):698-704.

Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research.

Author information

  • 1Department of Physiology & Biophysics, Georgetown University, Box 571460, Washington, District of Columbia 20057-1460, USA. fughberman@aol.com

Abstract

Seville orange (Citrus aurantium) extracts are being marketed as a safe alternative to ephedra in herbal weight-loss products, but C. aurantium may also have the potential to cause adverse health effects. C. aurantium contains synephrine (oxedrine), which is structurally similar to epinephrine. Although no adverse events have been associated with ingestion of C. aurantium products thus far, synephrine increases blood pressure in humans and other species, and has the potential to increase cardiovascular events. Additionally, C. aurantium contains 6',7'-dihydroxybergamottin and bergapten, both of which inhibit cytochrome P450-3A, and would be expected to increase serum levels of many drugs. There is little evidence that products containing C. aurantium are an effective aid to weight loss. Synephrine has lipolytic effects in human fat cells only at high doses, and octopamine does not have lipolytic effects in human adipocytes.

Comment in

PMID:
15337824
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk